Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjo Choi

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Plos Medicine|July 14, 2021
Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysisSarah Yu, Hojoon Sohn, Hae-Young Kim, et al.
Journal of Korean Medical Science|February 7, 2023
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST)Hongjo Choi, Jeongha Mok, Young Ae Kang, et al.
Yonsei Medical Journal|January 1, 2025
Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South KoreaHongjo Choi, Jeongha Mok, Young Ae Kang, et al.
The Korean Journal of Internal Medicine|February 5, 2024
Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort studyEunki Chung, Dawoon Jeong, Jeongha Mok, et al.
Journal of Korean Medical Science|October 24, 2012
Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in KoreaJoon Sung Joh, H Christian Hong, In A Jeong, et al.
ERJ Open Research|August 16, 2023
Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosisHongjo Choi, Jeongha Mok, Young Ae Kang, et al.
Tuberculosis and Respiratory Diseases|May 31, 2023
Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score MatchingHongjo Choi, Dawoon Jeong, Young Ae Kang, et al.
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
A molecular epidemiological analysis of tuberculosis trends in South KoreaKyungjong Kim, Jeong Seong Yang, Hongjo Choi, et al.
Annals of Thoracic Medicine|February 13, 2019
Investigation of false-positive <i>Mycobacterium tuberculosis</i> culture tests using whole genome sequencingJinsoo Min, Kyungjong Kim, Hongjo Choi, et al.
Journal of Korean Medical Science|November 26, 2024
Impact of Mass Screening Using Chest X-Ray on Mortality Reduction and Treatment Adherence Among Pulmonary Tuberculosis PatientsJi Yoon Baek, Sayada Zartasha Kazmi, Hyunmin Lee, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Plos Medicine|July 14, 2021
Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysisSarah Yu, Hojoon Sohn, Hae-Young Kim, et al.
Journal of Korean Medical Science|February 7, 2023
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST)Hongjo Choi, Jeongha Mok, Young Ae Kang, et al.
Yonsei Medical Journal|January 1, 2025
Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South KoreaHongjo Choi, Jeongha Mok, Young Ae Kang, et al.
The Korean Journal of Internal Medicine|February 5, 2024
Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort studyEunki Chung, Dawoon Jeong, Jeongha Mok, et al.
Journal of Korean Medical Science|October 24, 2012
Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in KoreaJoon Sung Joh, H Christian Hong, In A Jeong, et al.
ERJ Open Research|August 16, 2023
Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosisHongjo Choi, Jeongha Mok, Young Ae Kang, et al.
Tuberculosis and Respiratory Diseases|May 31, 2023
Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score MatchingHongjo Choi, Dawoon Jeong, Young Ae Kang, et al.
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
A molecular epidemiological analysis of tuberculosis trends in South KoreaKyungjong Kim, Jeong Seong Yang, Hongjo Choi, et al.
Annals of Thoracic Medicine|February 13, 2019
Investigation of false-positive <i>Mycobacterium tuberculosis</i> culture tests using whole genome sequencingJinsoo Min, Kyungjong Kim, Hongjo Choi, et al.
Journal of Korean Medical Science|November 26, 2024
Impact of Mass Screening Using Chest X-Ray on Mortality Reduction and Treatment Adherence Among Pulmonary Tuberculosis PatientsJi Yoon Baek, Sayada Zartasha Kazmi, Hyunmin Lee, et al.
Pageof 6